Femasys, Inc. (FEMY)
2.98
+0.02
(+0.68%)
USD |
NASDAQ |
Aug 24, 16:00
2.90
-0.08
(-2.68%)
After-Hours: 20:00
Femasys Debt to Equity Ratio : 1.188 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.188 |
| March 31, 2026 | 0.6486 |
| December 31, 2025 | 0.8003 |
| September 30, 2025 | 1.850 |
| June 30, 2025 | 5.209 |
| March 31, 2025 | 3.839 |
| December 31, 2024 | 3.230 |
| September 30, 2024 | 1.212 |
| June 30, 2024 | 0.6278 |
| March 31, 2024 | 0.4402 |
| December 31, 2023 | 0.3651 |
| September 30, 2023 | 0.2741 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.0162 |
| March 31, 2023 | 0.0247 |
| December 31, 2022 | 0.0357 |
| September 30, 2022 | 0.0435 |
| June 30, 2022 | 0.0488 |
| March 31, 2022 | 0.032 |
| December 31, 2021 | 0.0376 |
| September 30, 2021 | 0.0431 |
| June 30, 2021 | 0.049 |
| March 31, 2021 | -1.070 |
| December 31, 2020 | -1.108 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.638 |
| AngioDynamics, Inc. | 0.0641 |
| Alphatec Holdings, Inc. | 52.37 |
| AtriCure, Inc. | 0.1437 |
| Baxter International, Inc. | 1.427 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 12.29M |
| Total Liabilities (Quarterly) | 8.259M |
| Shareholders Equity (Quarterly) | 4.031M |
| Current Ratio | 2.144 |
| Net Debt Paydown Yield | 4.55% |